| Stephan A Sammartino Iv, CNP | |
|
1 Perkins Sq, Akron, OH 44308-1063 | |
| (305) 438-4523 | |
| (330) 543-3761 |
| Full Name | Stephan A Sammartino Iv |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 1 Perkins Sq, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083242747 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | APRN.CNP.025899 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephan A Sammartino Iv, CNP 1 Perkins Sq, Akron, OH 44308-1063 Ph: (330) 543-8452 | Stephan A Sammartino Iv, CNP 1 Perkins Sq, Akron, OH 44308-1063 Ph: (305) 438-4523 |
News Archive
Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs were regarded as potential agents in the fight against the coronavirus SARS-CoV-2.
A new low-dose abdominal computed tomography (CT) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with abdominal CT scans by 23-66 percent, according to a study in the September issue of the American Journal of Roentgenology.
Dexcom, Inc. today announced that it has received CE Mark approval for its fourth generation continuous glucose monitoring system, the Dexcom G4 system, enabling commercialization of the Dexcom G4 system in the European Union and the countries in Asia and Latin America that recognize the CE Mark.
MP Biomedicals CEO Milan Panic and RUSNANO CEO Anatoly Chubais have signed an agreement of cooperation. The parties have agreed to cooperate in the areas of nanotechnology research and development, in creation and modernization of an R&D base, and in providing due conditions for production of innovative pharmaceuticals, including personal pharmacogenetic treatments.
Actamax Surgical Materials LLC, a DSM-DuPont Joint Venture focusing on the development and commercialization of resorbable, biocompatible surgical medical devices, today announced positive safety and efficacy results from the first clinical evaluation of its novel adhesion barrier device.
› Verified 7 days ago
Shakeilah Carelle Burns, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 S Arlington St Unit 146, Akron, OH 44306 Phone: 330-355-7055 | |
Felicia Zabala, APRN. CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-5995 | |
Mrs. Molly A. Hockin, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 340 S Broadway St, Akron, OH 44308 Phone: 330-253-3100 | |
Sarah Elizabeth Bailey, CNP-APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 444 W Exchange St, Akron, OH 44302 Phone: 330-535-2671 | |
Heather Larson, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-6060 Fax: 330-543-6069 | |
Mrs. Erika Lynn Gross, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 160, Akron, OH 44302 Phone: 330-344-6505 | |
Lisa Young, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 |